Gestodene/EE Patch (BAY86-5016)

DRUG5 trials

Sponsors

Bayer

Conditions

Contraception

Phase 1

Relative Bioavailability, Transdermally Administered EE and GSD, 3 Applications Sites

CompletedNCT01083264

BayerContraception

Start: 2009-10-31End: 2010-05-31Updated: 2014-06-23

Phase 2

FC Patch Low: Metabolism Study

CompletedNCT00933179

BayerContraception

Start: 2009-06-30End: 2010-09-30Updated: 2014-11-14

Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women.

CompletedNCT01204190

BayerContraception

Start: 2010-09-30End: 2011-08-31Updated: 2014-11-04

Russia/Ukraine Suppression of Ovarian Activity Study

CompletedNCT02550977

BayerContraception

Start: 2015-09-18End: 2016-08-15Updated: 2017-08-07

Phase 3

Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles

CompletedNCT00910637

BayerContraception

Start: 2009-05-01End: 2010-12-13Updated: 2021-04-08